(Editor’s note: Posting opinion pieces does not necessarily reflect the opinions of Rose Law Group.)
By Dr. Sue Sisley, assistant director of interprofessional education and assistant professor of internal medicine and psychiatry at the University of Arizona
In her Dec. 1 op-ed on AZ Central, Yavapai County Attorney Sheila Polk echoed a misleading statement from the National Institute on Drug Abuse (NIDA) website claiming that the agency “permits or funds studies on therapeutic benefits of marijuana.”
A 1999 guidance issued by the Department of Health and Human Services expressly forbids NIDA from providing marijuana for studies intended to develop the marijuana plant into a prescription medicine approved by the Food and Drug Administration.
The National Cancer Institute study cited by Ms. Polk was on isolated cannabinoids, not the marijuana plant.
If you’d like to discuss medical marijuana, contact Ryan Hurley, director of the Rose Law Group Medical Marijuana Dept. rhurley@roselawgroup.com